BiOptic Inc.

股票代號 6850

You have 0 products on your cart

Total
$ USD

VIEW CART

PAY Now

Instruments

Instruments

Qsep Series & Qamp

Consumables

Consumables

DNA, RNA & Protein Cartridges

Reagents

Reagents

PCR, RT-PCR

Qexp Test Kits

Qexp Test Kits

MDx, FS Series

BiOptic Inc.

Leader in Innovative Capillary Electrophoresis Products.

BiOptic Inc. is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications.

Next Generation Sequencing (NGS)

Next Generation Sequencing (NGS)

Next Generation Sequencing (NGS) is a widely used technology in many fields, including genomics, epigenetics, transcriptome, etc. NGS is not only used in basic research but also applied for clinical diagnostics such as cancer screening and drug development.

High Resolution

High Resolution

DNA sample with 1 bp different can be resolved on Qsep Series platforms

CRISPR/Cas

CRISPR/Cas

CRISPR is a Genome Engineering technique that uses protein to interact with DNA. Genome editing begins with dsDNA cleavage. Cas9 is a dual-RNA-guided dsDNA endonuclease that is programmed by a single chimeric RNA. The guide RNA positions the Cas9 enzyme to the correct position on the target DNA for cleavage.

Recent News

BiOptic at the Exosome Industry Workshop | From Cell Authentication to Quality Control

Jun 30, 2026

We sincerely thank Creative Life Science for inviting us to join the Exosome Industry Practical Exchange to share Cell Authentication and Contamination Monitoring, highlighting the importance of cell identity recognition, contamination monitoring and source identification, and quality control throughout bioprocess workflows.

Expanding Opportunities in Indonesia’s Precision Health Market

Jun 25, 2026

BiOptic recently joined the Taiwan Biotechnology & Healthcare Industry Trade Mission in Jakarta, connecting with industry partners from Taiwan and Indonesia to explore opportunities in Southeast Asia's growing precision health market.

From Geneva to Global Collaboration | BiOptic at the WHA Taiwan Smart Healthcare Exhibition

May 22, 2026

A meaningful chapter concluded at the WHA Taiwan Smart Healthcare & Health Industry Exhibition in Geneva.
We sincerely appreciate the support and leadership of the Ministry of Foreign Affairs Taiwan and the Ministry of Health and Welfare, with implementation support from TAITRA Global (Taiwan External Trade Development Council), for organizing the event that showcased Taiwan’s strengths in building a sustainable global healthcare ecosystem.

Taiwan Smart Medical & HealthTech Expo Geneva 2026

May 12, 2026

BiOptic is honored to represent Taiwan at the Taiwan Smart Medical & HealthTech Expo, Geneva 2026, taking place alongside the 79th World Health Assembly (WHA79) in Geneva.

BiOptic Visits Japanese Partner for Strategic Discussions and Regulatory Milestone Achievement

Apr 24, 2026

We sincerely thank our partner in Japan, Otsuka Electronics Co., Ltd. for their thoughtful arrangement of this visit, which ensured smooth and productive discussions on strategic collaboration, potential customers, and refinement opportunities for Qsep Ultra.
With their invaluable support, BiOptic has successfully obtained the Registration Certificate for Foreign Medical Device Manufacturers and the Registration Certificate for Foreign In Vitro Diagnostic (IVD) Manufacturers in Japan.

PacBio PRISM 2026 in Spain, USA and Japan

Apr 07, 2026

We’re excited to be a sponsor of PacBio PRISM 2026 and to connect with the global genomics community at multiple events this spring.